Pharmacy benefit manager Express Scripts Holding Co. is looking for other opportunities to redirect manufacturer rebates toward reducing cost sharing for specific drugs at the pharmacy counter after reaching such a deal with Sanofi and Regeneron Pharmaceuticals Inc. for Praluent (alirocumab), according to the pharmacy benefit manager's Chief Medical Officer, Steve Miller.
The marketers of the PCSK9-inhibitor announced a novel contract with the PBM for Praluent on May 1. The contract calls...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?